AnalystsInsight

Yuan Zhi (B. Riley Securities): Analyst Track Record and Price‑Target Accuracy

How often Yuan Zhi’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 250 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Yuan Zhi ranks #925 of 1,000 analysts in Exent’s scoring (4.5★).
  • 28.8% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 67 days; 28.9% of calls were up 12 months later.
  • Most‑covered stocks: LNTH, CYRX, CATX, AZTA.
  • Free on Exent: Yuan Zhi’s full record, with ratings 3 days after publication.

Yuan Zhi’s track record at a glance

Yuan Zhi of B. Riley Securities ranks #925 of the 1,000 analysts Exent scores, with a 4.5★ rating and a focus on healthcare. Over a 7‑year lookback, 28.8% of Yuan’s price targets were reached, 23.6 points below the 52.4% average across all analysts.

MetricYuan ZhiAll analysts
Price‑target hit rate28.8%52.4%
Median days to hit target67 days91 days
Calls up after 12 months28.9%64.0%
Median 12‑month return of calls−19.0%+13.4%
Hit rate, last 2 years45.3%—
Average worst drop after a call−37.8%—
Ratings in the sample250—
Stocks covered15—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetYuan Zhi
Under 30 days35.3%
30–90 days20.6%
90–180 days32.4%
Over 180 days11.8%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Yuan Zhi covers most

StockRatings in the sample
LNTH59
CYRX35
CATX31
AZTA28
ATNM26
MIR25
HYPR22
TNGX18

In the past year Yuan’s ratings were 98% Buy, 2% Hold and 0% Sell.

Yuan Zhi’s latest ratings

DateStockActionRatingPrice target
Sep 4, 2026NUTXReiterated: BuyBuy$325.00
Aug 18, 2026LNTHDowngraded: HoldHold$105.40
Aug 10, 2026HYPRReiterated: BuyBuy$1.60
Aug 7, 2026STLNReiterated: BuyBuy$11.00
Jul 30, 2026MIRReiterated: BuyBuy$29.00
Jul 29, 2026LNTHReiterated: BuyBuy$129.00
Jul 22, 2026LYELInitiated Coverage: BuyBuy$44.00
Jul 21, 2026MIRInitiated Coverage: BuyBuy$29.00
Jul 9, 2026LNTHRated: BuyBuy$129.00
Jun 25, 2026WHWKInitiated Coverage: BuyBuy$10.00
Jun 9, 2026TNGXRatedBuy$35.00
Jun 9, 2026TNGXRated: BuyBuy$35.00
  • Sep 4, 2026
    Stock
    NUTX
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $325.00
  • Aug 18, 2026
    Stock
    LNTH
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $105.40
  • Aug 10, 2026
    Stock
    HYPR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $1.60
  • Aug 7, 2026
    Stock
    STLN
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $11.00
  • Jul 30, 2026
    Stock
    MIR
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $29.00
  • Jul 29, 2026
    Stock
    LNTH
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $129.00
  • Jul 22, 2026
    Stock
    LYEL
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $44.00
  • Jul 21, 2026
    Stock
    MIR
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $29.00
  • Jul 9, 2026
    Stock
    LNTH
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $129.00
  • Jun 25, 2026
    Stock
    WHWK
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $10.00
  • Jun 9, 2026
    Stock
    TNGX
    Action
    Rated
    Rating
    Buy
    Price target
    $35.00
  • Jun 9, 2026
    Stock
    TNGX
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $35.00

Yuan’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Yuan Zhi’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Yuan Zhi ranks #925 of 1,000 with a 4.5★ rating. 28.8% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 28.9% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Yuan Zhi’s success rate is 40.9% by the ranking source and 28.8% by Exent’s price-target hit-rate backtest, with a median of 67 days to reach a target.

Yuan Zhi (B. Riley Securities) covers 15 stocks, mostly in healthcare. The most frequently rated are LNTH, CYRX, CATX, AZTA, ATNM.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.